These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 7515019)

  • 1. The management of chronic lymphocytic leukemia at a single centre over a 24-year period: prognostic factors for survival.
    Karmiris T; Rohatiner AZ; Love S; Carter M; Ganjoo RK; Amess J; Norton AJ; Lister TA
    Hematol Oncol; 1994; 12(1):29-39. PubMed ID: 7515019
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic significance of lymphocyte morphology in patients with advanced chronic lymphocytic leukemia treated with first line therapy of fludarabine + prednisone.
    Mauro FR; Gentile M; Mancini F; Giannarelli D; Guarini A; De Propriis MS; Cerretti R; Foa R
    Haematologica; 2002 Jun; 87(6):602-8. PubMed ID: 12031916
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High dose chlorambucil versus Binet's modified cyclophosphamide, doxorubicin, vincristine, and prednisone regimen in the treatment of patients with advanced B-cell chronic lymphocytic leukemia. Results of an international multicenter randomized trial. International Society for Chemo-Immunotherapy, Vienna.
    Jaksic B; Brugiatelli M; Krc I; Losonczi H; Holowiecki J; Planinc-Peraica A; Kusec R; Morabito F; Iacopino P; Lutz D
    Cancer; 1997 Jun; 79(11):2107-14. PubMed ID: 9179056
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Watch and Wait in Lebanese Chronic Lymphocytic Leukemia Patients: How Relevant is it?
    Lutfallah AA; Kourie HR; Eid R; Farhat F; Ghosn M; Kattan J
    Asian Pac J Cancer Prev; 2016; 17(1):215-7. PubMed ID: 26838212
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new combination chemotherapy for advanced chronic lymphocytic leukemia (vincristine, cyclophosphamide, melphalan, peptichemio, and prednisone protocol).
    Ferrara F; Del Vecchio L; Mele G; Rametta V; Ronconi F; Montuori R
    Cancer; 1989 Aug; 64(4):789-92. PubMed ID: 2743271
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of chlorambucil and prednisone versus cyclophosphamide, vincristine, and prednisone as initial treatment for chronic lymphocytic leukemia: long-term follow-up of an Eastern Cooperative Oncology Group randomized clinical trial.
    Raphael B; Andersen JW; Silber R; Oken M; Moore D; Bennett J; Bonner H; Hahn R; Knospe WH; Mazza J
    J Clin Oncol; 1991 May; 9(5):770-6. PubMed ID: 2016618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of fludarabine, cyclophosphamide/doxorubicin/prednisone, and cyclophosphamide/doxorubicin/vincristine/prednisone in advanced forms of chronic lymphocytic leukemia: preliminary results of a controlled clinical trial. The French Cooperative Group on Chronic Lymphocytic Leukemia.
    Semin Oncol; 1993 Oct; 20(5 Suppl 7):21-3. PubMed ID: 8235691
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemotherapeutic options in chronic lymphocytic leukemia: a meta-analysis of the randomized trials. CLL Trialists' Collaborative Group.
    J Natl Cancer Inst; 1999 May; 91(10):861-8. PubMed ID: 10340906
    [TBL] [Abstract][Full Text] [Related]  

  • 9. When and how to treat elderly patients with chronic lymphocytic leukemia (C.L.L.)? The French Cooperative Group on C.L.L.
    Binet JL
    Hematol Oncol; 1993; 11 Suppl 1():38. PubMed ID: 8486339
    [No Abstract]   [Full Text] [Related]  

  • 10. Response to fludarabine in B-cell chronic lymphocytic leukemia patients previously treated with chlorambucil as up-front therapy and a CHOP-like regimen as second line therapy.
    Liso V; Molica S; Capalbo S; Pogliani E; Battista C; Broccia G; Montillo M; Cuneo A; Leoni P; Specchia G; Castoldi G
    Haematologica; 2001 Nov; 86(11):1165-71. PubMed ID: 11694402
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of residual disease in B-cell chronic lymphocytic leukemia patients in clinical and bone-marrow remission using CD5-CD19 markers and PCR study of gene rearrangements.
    Vuillier F; Claisse JF; Vandenvelde C; Travade P; Magnac C; Chevret S; Desablens B; Binet JL; Dighiero G
    Leuk Lymphoma; 1992 Jun; 7(3):195-204. PubMed ID: 1282428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical and laboratory prognostic parameters for leukemic types of chronic lymphoproliferative diseases].
    Kardum-Skelin I; Planinc-Peraica A; Ostojić Kolonić S; Radić-Kristo D; Milas M; Vrhovac R; Sustercić D; Minigo H; Jaksić B
    Acta Med Croatica; 2008 Oct; 62(4):351-64. PubMed ID: 19205412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Chronic lymphocytic leukemia].
    Maurer C; Hallek M
    Dtsch Med Wochenschr; 2013 Oct; 138(42):2153-66. PubMed ID: 24104591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CHOP regimen versus intermittent chlorambucil-prednisone in stage B chronic lymphocytic leukemia. Short term results from a randomized clinical trial. French Cooperative Group on Chronic Lymphocytic Leukemia.
    Nouv Rev Fr Hematol (1978); 1988; 30(5-6):449-52. PubMed ID: 2906118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early stem cell transplantation for chronic lymphocytic leukaemia: a chance for cure?
    Dreger P; von Neuhoff N; Kuse R; Sonnen R; Glass B; Uharek L; Schoch R; Löffler H; Schmitz N
    Br J Cancer; 1998 Jun; 77(12):2291-7. PubMed ID: 9649148
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fludarabine compared with chlorambucil as primary therapy for chronic lymphocytic leukemia.
    Rai KR; Peterson BL; Appelbaum FR; Kolitz J; Elias L; Shepherd L; Hines J; Threatte GA; Larson RA; Cheson BD; Schiffer CA
    N Engl J Med; 2000 Dec; 343(24):1750-7. PubMed ID: 11114313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The UK Medical Research Council CLL trials 1 and 2.
    Catovsky D; Fooks J; Richards S
    Nouv Rev Fr Hematol (1978); 1988; 30(5-6):423-7. PubMed ID: 3222154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Presenting features and treatment outcomes of chronic lymphocytic leukaemia in a resource poor Southern Nigeria.
    Madu AJ; Korubo K; Okoye A; Ajuba I; Duru AN; Ugwu AO; Nnachi O; Okoye HC
    Malawi Med J; 2019 Jun; 31(2):144-149. PubMed ID: 31452848
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Chronic lymphocytic leukemia in Subsaharian Africa: clinical outcome experience of Côte d'Ivoire].
    Koffi KG; Nanho DC; Tolo A; N'Dathz E; Kouakou B; Meite N; Ayemou R; Sanogo I
    Bull Cancer; 2009 Sep; 96(9):901-6. PubMed ID: 19696007
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic lymphocytic leukemia in the recent 10 years and treatment effects of Fludarabin.
    Kermani IA; Dehdilani M; Dolatkhah R
    Asian Pac J Cancer Prev; 2007; 8(3):367-71. PubMed ID: 18159969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.